--- title: "Saunders C Hsu, M.D., MPH | Sutter Health" url: "https://www.sutterhealth.org/research/investigators/saunders-c-hsu-md-mph-1049681145" --- 1. [Home](https://www.sutterhealth.org/) / 2. [Research](https://www.sutterhealth.org/research) / 3. [Investigators](https://www.sutterhealth.org/research/investigators) / 4. Saunders C Hsu, M.D., MPH ![Saunders C Hsu, M.D., MPH](https://dyn.mktgcdn.com/p/K3ZX5N0y7N6WNIDOgrYaCtGzwAnwP-Hi9QS2TxBNPo0/fit=crop,gravity=auto,dpr=2,width=240,height=240) # Saunders C Hsu, M.D., MPH Investigator [View profile](https://www.sutterhealth.org/find-provider/dr-saunders-c-hsu-1046243089) Saunders C. Hsu, MD, MPH is a pediatric hematologist-oncologist currently practicing with Sutter Medical Group. Dr. Hsu has over two decades of experience in pediatric hematology and oncology, previously serving with Northern California Children’s Hematology/Oncology Medical Group from 2006 to 2025. He completed his pediatric residency at SUNY Brooklyn Health Science Center and fellowship training in hematology/oncology at Oregon Health & Science University, where he also earned a Master of Public Health. Dr. Hsu received his medical degree from the University of Illinois College of Medicine and holds a bachelor’s degree in chemical engineering from the Massachusetts Institute of Technology. His career includes diverse clinical and research experiences, including global health work in Thailand and service as a physician in Alaska, as well as laboratory research focused on cancer diagnostics and immunology. 5030 J Street Suite 200 Sacramento, CA 95819 ## Clinical trials - Clinical trial ### [Cancer Young Female Adults Ovarian Damage Prevention ALTE2131](https://www.sutterhealth.org/research/clinical-trials/cancer-young-female-adults-ovarian-damage-prevention-alte2131-2027477841) Triptorelin and Protection of Ovarian Reserve in Adolescents and Young Adults With Cancer **Status:** Open to Enrollment - Clinical trial ### [Neoadjuvant Hodgkin Lymphoma COG AHOD2131](https://www.sutterhealth.org/research/clinical-trials/neoadjuvant-hodgkin-lymphoma-cog-ahod2131-2080025103) A Randomized Phase 3 Interim Response Adapted Trial Comparing Standard Therapy With Immuno-oncology Therapy for Children and Adults With Newly Diagnosed Stage I and II Classic Hodgkin Lymphoma **Status:** Open to Enrollment - Clinical trial ### [Neoadjuvant Neuroblastoma ANBL2131](https://www.sutterhealth.org/research/clinical-trials/neoadjuvant-neuroblastoma-anbl2131-2022194957) A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma **Status:** Open to Enrollment - Clinical trial ### [Neoadjuvant Pediatric Leukemia AALL1821](https://www.sutterhealth.org/research/clinical-trials/neoadjuvant-pediatric-leukemia-aall1821-1049141818) A Phase 2 Study of Blinatumomab (NSC# 765986) in Combination With Nivolumab (NSC # 748726), a Checkpoint Inhibitor of PD-1, in B-ALL Patients Aged >/= 1 to < 31 Years Old With First Relapse. **Status:** Open to Enrollment - Clinical trial ### [Pediatric B-Lymphoblastic Leukemia COG AALL1732](https://www.sutterhealth.org/research/clinical-trials/cogaall1732-1049141808) A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLyLy **Status:** Open to Enrollment Page 1 of 2 ```json {"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]} ``` ```json {"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/investigators/saunders-c-hsu-md-mph-1049681145#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Investigators","item":"https://www.sutterhealth.org/research/investigators"},{"@type":"ListItem","position":4,"name":"Saunders C Hsu, M.D., MPH"}]} ``` ```json {"@context":"https://schema.org","@type":"ProfilePage","@id":"https://www.sutterhealth.org/research/investigators/saunders-c-hsu-md-mph-1049681145#profilepage","url":"https://www.sutterhealth.org/research/investigators/saunders-c-hsu-md-mph-1049681145","name":"Saunders C Hsu, M.D., MPH","dateModified":"2026-06-09","breadcrumb":{"@id":"https://www.sutterhealth.org/research/investigators/saunders-c-hsu-md-mph-1049681145#breadcrumblist"},"primaryImageOfPage":{"@type":"ImageObject","contentUrl":"https://a.mktgcdn.com/p/K3ZX5N0y7N6WNIDOgrYaCtGzwAnwP-Hi9QS2TxBNPo0/460x460.webp","width":460,"height":460},"mainEntity":{"@id":"https://www.sutterhealth.org/research/investigators/saunders-c-hsu-md-mph-1049681145"}} ``` ```json {"@context":"https://schema.org","@type":"Person","@id":"https://www.sutterhealth.org/research/investigators/saunders-c-hsu-md-mph-1049681145","name":"Saunders C Hsu, M.D., MPH","givenName":"Saunders","additionalName":"C","familyName":"Hsu","honorificSuffix":"M.D., MPH","description":"Saunders C. Hsu, MD, MPH is a pediatric hematologist-oncologist currently practicing with Sutter Medical Group. Dr. Hsu has over two decades of experience in pediatric hematology and oncology, previously serving with Northern California Children’s Hematology/Oncology Medical Group from 2006 to 2025. He completed his pediatric residency at SUNY Brooklyn Health Science Center and fellowship training in hematology/oncology at Oregon Health & Science University, where he also earned a Master of Public Health. Dr. Hsu received his medical degree from the University of Illinois College of Medicine and holds a bachelor’s degree in chemical engineering from the Massachusetts Institute of Technology. His career includes diverse clinical and research experiences, including global health work in Thailand and service as a physician in Alaska, as well as laboratory research focused on cancer diagnostics and immunology.","image":{"@type":"ImageObject","contentUrl":"https://a.mktgcdn.com/p/K3ZX5N0y7N6WNIDOgrYaCtGzwAnwP-Hi9QS2TxBNPo0/460x460.webp","representativeOfPage":true},"address":{"@type":"PostalAddress","streetAddress":"5030 J Street Suite 200","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95819","addressCountry":"US"},"affiliation":{"@id":"https://www.sutterhealth.org/#medicalorganization"},"mainEntityOfPage":{"@id":"https://www.sutterhealth.org/research/investigators/saunders-c-hsu-md-mph-1049681145#profilepage"},"sameAs":"https://www.sutterhealth.org/find-provider/dr-saunders-c-hsu-1046243089"} ```